Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Piercer of microtubule wall 2 protein (PIERCE2) is a protein coding gene involved in the structure and function of ciliary axonemes, specifically acting as a microtubule inner protein that supports the attachment of outer dynein arms (ODAs) to dynein-decorated doublet microtubules in the axoneme, which is required for proper motile cilia beating[1]. It is localized within the axonemal microtubule and predicted to contribute to processes such as axoneme assembly, establishment of left-right symmetry during development, and the motility of flagellated sperm[1]. PIERCE2 lacks catalytic activity, acts as a structural or scaffolding component, and does not currently have known pharmaceutical ligands or roles as a canonical therapeutic target[3]. No direct disease associations or functional links to pathogenesis are established based on current human data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Piercer of microtubule wall 2 protein (PIERCE2).